secwatch / observer
8-K filed April 29, 2025, 7:59 PM ET CIK 0001124140
leadership confidence high sentiment neutral materiality 0.30

Exact Sciences appoints Leslie Trigg to Board; Kathleen Sebelius retires

EXACT SCIENCES CORP

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leslie Trigg

Director
EXACT SCIENCES CORP
Effective
2025-04-29
Filed
April 29, 2025, 7:59 PM ET
On April 29, 2025, the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) appointed Leslie Trigg as a Class II member of the Board with a term ending at the Company’s 2026 annual meeting of shareholders.
Departed

Kathleen Sebelius

Director
EXACT SCIENCES CORP
Effective
2025-04-29
Successor
Leslie Trigg
Filed
April 29, 2025, 7:59 PM ET
Ms. Trigg was appointed to fill the vacancy created by the resignation of Kathleen Sebelius (formerly a Class II director) from the Board on April 29, 2025 for her retirement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leslie Trigg was appointed as Director at EXACT SCIENCES CORP.

Action
appointed
Role
Director
Exact text from the filing
On April 29, 2025, the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) appointed Leslie Trigg as a Class II member of the Board with a term ending at the Company’s 2026 annual meeting of shareholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen Sebelius resigned as Director at EXACT SCIENCES CORP.

Action
resigned
Role
Director
Exact text from the filing
Ms. Trigg was appointed to fill the vacancy created by the resignation of Kathleen Sebelius (formerly a Class II director) from the Board on April 29, 2025 for her retirement.
View on SEC.gov
Source: SEC EDGAR
accession 0001124140-25-000032
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.